Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenomedullin and endothelial barrier function.

Bettina Temmesfeld-Wollbrück1, Andreas C Hocke, Norbert Suttorp

  • 1Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité--Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

Thrombosis and Haemostasis
|November 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Admission Eosinophil Count Is Associated With Hospital Resource Use in Community-Acquired Pneumonia: A Prospective Multicenter Study.

Chest·2026
Same author

Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract models.

The Journal of infection·2026
Same author

Lung tumouroids as a testing platform for precision CAR T cell therapy.

Nature biomedical engineering·2026
Same author

Blood eosinopenia (≤30/µL) as an early predictor of respiratory failure in community-acquired pneumonia: A prospective multicentre study.

Pulmonology·2026
Same author

Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study.

Infection·2025
Same author

Phage-phage competition and biofilms affect interactions between two virulent bacteriophages and Pseudomonas aeruginosa.

The ISME journal·2025
Same journal

Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of Randomized Clinical Trials.

Thrombosis and haemostasis·2026
Same journal

Novel/Recurrent Variants in Pakistani Glanzmann Thrombasthenia and Glanzmann-like bleeding diathesis: Insights from NGS Analysis.

Thrombosis and haemostasis·2026
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
See all related articles

Adrenomedullin (AM) peptide stabilizes endothelial barrier function, crucial for treating severe infections like sepsis. AM enhances cyclic adenosine monophosphate (cAMP) to prevent organ damage and cardiovascular issues.

Area of Science:

  • Cardiovascular Biology
  • Inflammation Research
  • Endothelial Cell Biology

Background:

  • Loss of endothelial barrier function is a critical factor in acute inflammation and severe infections, leading to organ dysfunction.
  • Current therapies for stabilizing endothelial barrier function are insufficient.
  • Serum levels of the endogenous peptide adrenomedullin (AM) increase during severe infections like sepsis and septic shock.

Purpose of the Study:

  • To investigate the therapeutic potential of adrenomedullin (AM) in stabilizing endothelial barrier function.
  • To explore the mechanisms by which AM exerts its protective effects.
  • To evaluate AM's efficacy in models of sepsis and septic shock.

Main Methods:

  • In vitro and in vivo experimental models were utilized.

Related Experiment Videos

  • Studies involved assessing endothelial barrier permeability and cell contraction.
  • Mechanisms investigated included cyclic adenosine monophosphate (cAMP) signaling pathways.

    • Main Results:

    • Adrenomedullin (AM) demonstrated potent endothelial barrier function-stabilizing effects in various models.
    • AM activation of receptors led to increased cAMP levels.
    • AM inhibited endothelial cell contraction and junctional disassembly, preventing permeability and edema.
    • AM exhibited protective cardiovascular qualities and counter-regulatory effects in sepsis models.

    Conclusions:

    • Adrenomedullin (AM) is a promising therapeutic agent for stabilizing endothelial barrier function during severe infections.
    • AM's mechanism involves cAMP elevation, inhibiting endothelial cell contraction and preventing paracellular permeability.
    • AM offers significant potential for combating cardiovascular dysfunction in sepsis and septic shock.